Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 33035457

Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2020 Nov
First author
Morschhauser F

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 Nov;21(11):1388-1390. doi: 10.1016/S1470-2045(20)30530-1.
    note
    Source null
    related pmid
    33035458
    relationship
    Comment in

Authors and identifiers

  1. name
    Morschhauser F
    type
    Author
  2. name
    Tilly H
    type
    Author
  3. name
    Chaidos A
    type
    Author
  4. name
    McKay P
    type
    Author
  5. name
    Phillips T
    type
    Author
  6. name
    Assouline S
    type
    Author
  7. name
    Batlevi CL
    type
    Author
  8. name
    Campbell P
    type
    Author
  9. name
    Ribrag V
    type
    Author
  10. name
    Damaj GL
    type
    Author
  11. name
    Dickinson M
    type
    Author
  12. name
    Jurczak W
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Morschhauser F
    type
    Author
  2. name
    Tilly H
    type
    Author
  3. name
    Chaidos A
    type
    Author
  4. name
    McKay P
    type
    Author
  5. name
    Phillips T
    type
    Author
  6. name
    Assouline S
    type
    Author
  7. name
    Batlevi CL
    type
    Author
  8. name
    Campbell P
    type
    Author
  9. name
    Ribrag V
    type
    Author
  10. name
    Damaj GL
    type
    Author
  11. name
    Dickinson M
    type
    Author
  12. name
    Jurczak W
    type
    Author
bibliography ids
  1. nci-bib-e34c4bbce5b8c37f15c7cc19
book metadata
content sha256
d9dd3ca5c6413056a99af72948b6c0fdad711a1c6c5bbe58c31523351fdaca04
document type
citation
dois
  1. 10.1016/S1470-2045(20)30441-1
electronic publication date
display
2020 Oct 6
precision
day
year
2020
evidence scope
bibliographic_metadata_only
id
pubmed:33035457
immutable id
pubmed:33035457@d9dd3ca5c6413056a99af72948b6c0fdad711a1c6c5bbe58c31523351fdaca04
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
11
name
The Lancet. Oncology
nlm unique id
100957246
pages
1433-1442
volume
21
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2020 Nov;21(11):1388-1390. doi: 10.1016/S1470-2045(20)30530-1.
    note
    Source null
    related pmid
    33035458
    relationship
    Comment in
outcomes validated
false
pmid
33035457
provenance
batch id
9bca82d1bba2b27adc79
provider
NCBI PubMed ESummary
record sha256
98a137b903827143b80345ecc3e00abfa7be54b0b0558616dc91d6f78cb0ccf7
response sha256
c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
retrieved at
2026-09-09T23:47:56.131551+00:00
publication date
display
2020 Nov
precision
month
year
2020
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33035457/
title
Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial.

Preserved source evidence · Independent clinical review pending · Not medical advice